TAME – CD19-targeted B-cell therapy for post-infectious autoimmune ME/CFS
Funding period: September 2026–December 2029
Since its establishment in 2022, the non profit ME/CFS Research Foundation has funded a range of biomedical ME/CFS research projects. These projects focus on the development of biomarkers, diagnostics, and treatment options.
The initial focus of our research funding was on supporting established centres of excellence for ME/CFS research in Germany: the Charité Fatigue Centre (CFC) and the Munich Chronic Fatigue Centre (MCFC). The Research Funding Programme 2026 expands our portfolio to include further projects and locations.
Filter projects
14 of 14 projects
Funding period: September 2026–December 2029
Funding period: September 2026–March 2029
Funding period: September 2026–August 2028
Funding period: September 2026–August 2028
Funding period: September 2026–August 2028
Funding period: September 2026–August 2028
Funding period: September 2026–August 2028
Funding period: January 2024–December 2026
Funding period: January 2026–June 2026
Funding period: January 2026–June 2026
Funding period: January 2024–December 2025
Funding period: January 2025–December 2025
Funding period: January 2025–December 2025
Funding period: January 2025–December 2025
Background
Read about how we select projects and why private funding matters for advancing ME/CFS research.
Learn moreSupport our work
Your donation enables new research projects and other important initiatives.
Donate now!